Compare Aurora Cannabis Inc (ACB) vs Stitch Fix Inc (SFIX) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

Stitch Fix (SFIX) trades at $3.72, down 3.12% on the day, as the company continues its turnaround efforts with improving financial metrics. The stock shows bearish technical signals but fundamental progress with narrowing losses, a 43.66% gross margin, and three consecutive quarterly earnings beats. Recent news highlights AI-driven personalization initiatives and growing client spending, though the company remains unprofitable with negative cash flow.

The outlook suggests cautious optimism as SFIX stabilizes revenue near $1.3B and reduces net losses. Investment opportunity lies in the discounted valuation (P/S 0.39) and AI growth potential, but risks include persistent unprofitability, competitive pressure, and execution challenges in achieving sustained positive cash flow.